Affinity DataKi: 22.8nM IC50: 140nMAssay Description:The radioligand binding assays were carried out at four different test concentrations and the test concentrations were 1 nM, 10 nM, 0.1 μM, and ...More data for this Ligand-Target Pair
Affinity DataKi: 45.2nM IC50: 56.9nMAssay Description:The radioligand binding assays were carried out at four different test concentrations and the test concentrations were 1 nM, 10 nM, 0.1 μM, and ...More data for this Ligand-Target Pair
Affinity DataKi: 67.6nM IC50: 415nMAssay Description:The radioligand binding assays were carried out at four different test concentrations and the test concentrations were 1 nM, 10 nM, 0.1 μM, and ...More data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Reviva Pharmaceuticals
US Patent
Reviva Pharmaceuticals
US Patent
Affinity DataKi: 120nM IC50: 121nMAssay Description:The radioligand binding assays were carried out at four different test concentrations and the test concentrations were 1 nM, 10 nM, 0.1 μM, and ...More data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Reviva Pharmaceuticals
US Patent
Reviva Pharmaceuticals
US Patent
Affinity DataKi: 180nM IC50: 182nMAssay Description:The radioligand binding assays were carried out at four different test concentrations and the test concentrations were 1 nM, 10 nM, 0.1 μM, and ...More data for this Ligand-Target Pair
Affinity DataKi: 294nM IC50: 370nMAssay Description:The radioligand binding assays were carried out at four different test concentrations and the test concentrations were 1 nM, 10 nM, 0.1 μM, and ...More data for this Ligand-Target Pair